Evaluating a Widely Implemented Proprietary Deterioration Index Model Among Hospitalized COVID-19 Patients.

Karandeep S Singh Thomas S ValleyShengpu TangBenjamin Y LiFahad KamranMichael W SjodingJenna WiensErkin ÖtleşJohn P DonnellyMelissa Y WeiJonathon P McBrideJie CaoCarleen PenozaJohn Z AyanianBrahmajee K Nallamothu

Published in: medRxiv : the preprint server for health sciences (2020)

We found the EDI identifies small subsets of high- and low-risk COVID-19 patients with fair discrimination. We did not find evidence of bias by race or sex. These findings highlight the importance of independent evaluation of proprietary models before widespread operational use among COVID-19 patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
genome wide
peripheral blood
gene expression
dna methylation